These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27031484)

  • 1. A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging.
    Tanifum EA; Ghaghada K; Vollert C; Head E; Eriksen JL; Annapragada A
    J Alzheimers Dis; 2016; 52(2):731-45. PubMed ID: 27031484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
    Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
    J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo detection of amyloid β deposition using ¹⁹F magnetic resonance imaging with a ¹⁹F-containing curcumin derivative in a mouse model of Alzheimer's disease.
    Yanagisawa D; Amatsubo T; Morikawa S; Taguchi H; Urushitani M; Shirai N; Hirao K; Shiino A; Inubushi T; Tooyama I
    Neuroscience; 2011 Jun; 184():120-7. PubMed ID: 21497641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging beta amyloid aggregation and iron accumulation in Alzheimer's disease using quantitative susceptibility mapping MRI.
    Gong NJ; Dibb R; Bulk M; van der Weerd L; Liu C
    Neuroimage; 2019 May; 191():176-185. PubMed ID: 30739060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced MR microscopy of amyloid plaques in five mouse models of amyloidosis and in human Alzheimer's disease brains.
    Dudeffant C; Vandesquille M; Herbert K; Garin CM; Alves S; Blanchard V; Comoy EE; Petit F; Dhenain M
    Sci Rep; 2017 Jul; 7(1):4955. PubMed ID: 28694463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI).
    Cheng KK; Chan PS; Fan S; Kwan SM; Yeung KL; Wáng YX; Chow AH; Wu EX; Baum L
    Biomaterials; 2015 Mar; 44():155-72. PubMed ID: 25617135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease.
    Badachhape AA; Working PK; Srivastava M; Bhandari P; Stupin IV; Devkota L; Tanifum EA; Annapragada AV; Ghaghada KB
    Sci Rep; 2020 Sep; 10(1):16185. PubMed ID: 32999398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.
    Ghaghada KB; Ravoori M; Sabapathy D; Bankson J; Kundra V; Annapragada A
    PLoS One; 2009 Oct; 4(10):e7628. PubMed ID: 19893616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging.
    Yang J; Wadghiri YZ; Hoang DM; Tsui W; Sun Y; Chung E; Li Y; Wang A; de Leon M; Wisniewski T
    Neuroimage; 2011 Apr; 55(4):1600-9. PubMed ID: 21255656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging.
    Wadghiri YZ; Li J; Wang J; Hoang DM; Sun Y; Xu H; Tsui W; Li Y; Boutajangout A; Wang A; de Leon M; Wisniewski T
    PLoS One; 2013; 8(2):e57097. PubMed ID: 23468919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.
    Poduslo JF; Wengenack TM; Curran GL; Wisniewski T; Sigurdsson EM; Macura SI; Borowski BJ; Jack CR
    Neurobiol Dis; 2002 Nov; 11(2):315-29. PubMed ID: 12505424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic mice.
    Tanifum EA; Dasgupta I; Srivastava M; Bhavane RC; Sun L; Berridge J; Pourgarzham H; Kamath R; Espinosa G; Cook SC; Eriksen JL; Annapragada A
    PLoS One; 2012; 7(10):e48515. PubMed ID: 23119043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice.
    Petiet A; Santin M; Bertrand A; Wiggins CJ; Petit F; Houitte D; Hantraye P; Benavides J; Debeir T; Rooney T; Dhenain M
    Neurobiol Aging; 2012 Aug; 33(8):1533-44. PubMed ID: 21531045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.
    Poduslo JF; Curran GL; Peterson JA; McCormick DJ; Fauq AH; Khan MA; Wengenack TM
    Biochemistry; 2004 May; 43(20):6064-75. PubMed ID: 15147190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast Enhanced Magnetic Resonance Imaging of Amyloid-β Plaques in a Murine Alzheimer's Disease Model.
    Sulheim E; WiderØe M; Bäck M; Nilsson KPR; Hammarström P; Nilsson LNG; Davies CL; Åslund AKO
    J Alzheimers Dis; 2023; 93(2):411-419. PubMed ID: 37038807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast in vivo imaging of amyloid plaques using μ-MRI Gd-staining combined with ultrasound-induced blood-brain barrier opening.
    Santin MD; Debeir T; Bridal SL; Rooney T; Dhenain M
    Neuroimage; 2013 Oct; 79():288-94. PubMed ID: 23660031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand.
    Juréus A; Swahn BM; Sandell J; Jeppsson F; Johnson AE; Johnström P; Neelissen JA; Sunnemark D; Farde L; Svensson SP
    J Neurochem; 2010 Aug; 114(3):784-94. PubMed ID: 20477945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting vascular amyloid in arterioles of Alzheimer disease transgenic mice with amyloid β protein antibody-coated nanoparticles.
    Poduslo JF; Hultman KL; Curran GL; Preboske GM; Chamberlain R; Marjańska M; Garwood M; Jack CR; Wengenack TM
    J Neuropathol Exp Neurol; 2011 Aug; 70(8):653-61. PubMed ID: 21760540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice.
    Sigurdsson EM; Wadghiri YZ; Mosconi L; Blind JA; Knudsen E; Asuni A; Scholtzova H; Tsui WH; Li Y; Sadowski M; Turnbull DH; de Leon MJ; Wisniewski T
    Neurobiol Aging; 2008 Jun; 29(6):836-47. PubMed ID: 17291630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice.
    Li S; He H; Cui W; Gu B; Li J; Qi Z; Zhou G; Liang CM; Feng XY
    Anat Rec (Hoboken); 2010 Dec; 293(12):2136-43. PubMed ID: 21089051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.